Navigation Links
Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association
Date:1/28/2011

FAIRFIELD, N.J., Jan. 28, 2011 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) announced that its 2011 "Woman of the Year" is Freda Lewis-Hall, MD, chief medical officer of Pfizer. In her distinguished 30-year career, Dr. Lewis-Hall has held leadership roles in direct patient care, academics, media, government, pharmaceuticals and biotechnology.

(Photo: http://photos.prnewswire.com/prnh/20110128/DC38263)

"I am deeply honored to be named Woman of the Year by the Healthcare Businesswomen's Association," said Dr. Lewis-Hall. "HBA has been an agent of positive growth for many women who have made great contributions to the advancement of healthcare. To have been nominated for this award by my fellow members of the healthcare community is especially meaningful to me. Whether we're in industry, academia, government, or the non-profit arena, we share a common goal: to improve the quality of healthcare for all patients."

Dr. Lewis-Hall will be honored at the HBA's 22nd annual "Woman of the Year" Luncheon on Thursday, May 5, at the Hilton New York. This is the event of the year for the healthcare community, attended by nearly 2,500 leaders in the industry. Awards for Honorable Mentor, the Star Volunteer, and a group of some 100 "Rising Stars," noted for their accomplishments and contributions to the healthcare industry, will also be presented at the luncheon.

"The Healthcare Businesswomen's Association is extremely proud to honor Freda Lewis-Hall as our 2011 Woman of the Year," says Deborah Coogan Seltzer, president of the HBA and life sciences practice member at Spencer Stuart. "Dr. Lewis-Hall sets the tone for all of us with her unique abilities as a talented physician and leader. She has a longstanding commitment to the social responsibilities of healthcare leadership – especially in making sure that people have the education and understanding to make the best healthcare decisions."

"Freda defines what it means to be a leader in today's rapidly changing healthcare industry. She has a genuine and singular passion to improve the lives of patients – a passion that motivates and energizes her colleagues at Pfizer and everyone with whom she interacts. She has been a dedicated mentor and an inspiring role model to hundreds of women and men in industry, academia and medical practice," said Ian Read, CEO and president of Pfizer. "Freda is intensely engaged in critical policy dialog in the interest of better patient outcomes. We are fortunate to have her as our top physician ensuring the quality, safety and effective use of Pfizer medicines."

In September 2010, Dr. Lewis-Hall was appointed by the Government Accountability Office of the United States to the inaugural Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI). Established through the healthcare reform law, PCORI will prioritize and direct a range of research programs to improve the nation's quality of healthcare.

In 2009, Dr. Lewis-Hall was one of 15 women spotlighted by ForbesWoman as a role model for young women in science. She was recognized in 2010 as one of the 25 Most Influential African-Americans in Healthcare by Black Health magazine and as one of the 75 Most Powerful Women in Business by Black Enterprise magazine. Over the course of her career, Dr. Lewis-Hall has personally mentored more than 100 women.

Dr. Lewis-Hall has a strong record of patient advocacy, and she has spoken extensively on the impact of mental illnesses on patients, families and communities. She is a vocal champion of the imperatives to break down cultural barriers and eliminate healthcare disparities, often working closely with members of the Health Brain Trust of the Congressional Black Caucus.

Dr. Lewis-Hall earned her undergraduate degree from The Johns Hopkins University and her medical doctorate from Howard University College of Medicine. She is a Fellow of the American Psychiatric Association and serves on a number of boards, including the Society for the Advancement of Women's Health Research, the Foundation of the National Institutes of Health, and the Board of Fellows of Harvard Medical School.

The 2011 HBA nominating committee overwhelmingly agreed that Dr. Lewis-Hall's many accomplishments demonstrate her fulfillment of the criteria for Woman of the Year, including success in the healthcare industry, strong leadership capabilities, proven mentoring skills, dedication, a commitment to giving back to women, and contributions to the community. Letters of nomination were received for Dr. Lewis-Hall from across the healthcare spectrum, including public sector leaders.

About The HBA

The Healthcare Businesswomen's Association (HBA; http://www.hbanet.org) is in its fourth decade as a global not-for-profit organization dedicated to furthering the advancement of women in healthcare worldwide. With 15 chapters and affiliates throughout the US and in Europe, the HBA is headquartered in New Jersey with offices in Philadelphia and Research Triangle Park. The HBA provides educational opportunities for women and men to develop cutting-edge healthcare industry knowledge and leadership skills; recognizes outstanding women and men in the industry; provides opportunities for networking; creates greater visibility for women in the industry; fosters mentoring relationships and serves as a conduit and sponsor for research on career advancement issues. The HBA has over 6,000 individual members and 120 Corporate Partners. It is widely recognized as the catalyst for leadership development of women in healthcare worldwide. For more information, visit www.hbanet.org.


'/>"/>
SOURCE Healthcare Businesswomen's Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... , TwinLink™ - the first dual communication ...
(Date:6/23/2016)... June 23, 2016 The Biotechnology ... continues to present great opportunities to investors. Stock-Callers.com assesses ... Intrexon Corp. (NYSE: XON ), Vertex Pharmaceuticals ... (NASDAQ: ARNA ), and Regeneron Pharmaceuticals Inc. ... stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):